311 related articles for article (PubMed ID: 24715604)
1. Mapping EQ-5D utility scores from the PedsQL™ generic core scales.
Khan KA; Petrou S; Rivero-Arias O; Walters SJ; Boyle SE
Pharmacoeconomics; 2014 Jul; 32(7):693-706. PubMed ID: 24715604
[TBL] [Abstract][Full Text] [Related]
2. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.
Yang Q; Yu XX; Zhang W; Li H
Health Qual Life Outcomes; 2019 Oct; 17(1):153. PubMed ID: 31615531
[TBL] [Abstract][Full Text] [Related]
3. Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients.
Shafie AA; Chhabra IK; Wong JHY; Mohammed NS
Eur J Health Econ; 2021 Jul; 22(5):735-747. PubMed ID: 33860379
[TBL] [Abstract][Full Text] [Related]
4. Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.
Dakin H; Gray A; Murray D
Qual Life Res; 2013 Apr; 22(3):683-94. PubMed ID: 22555470
[TBL] [Abstract][Full Text] [Related]
5. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
6. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
[TBL] [Abstract][Full Text] [Related]
7. Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV.
Joyce VR; Sun H; Barnett PG; Bansback N; Griffin SC; Bayoumi AM; Anis AH; Sculpher M; Cameron W; Brown ST; Holodniy M; Owens DK
MDM Policy Pract; 2017; 2(2):2381468317716440. PubMed ID: 30288427
[No Abstract] [Full Text] [Related]
8. Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores.
Gu NY; Bell C; Botteman MF; Ji X; Carter JA; van Hout B
Patient; 2012; 5(3):185-97. PubMed ID: 22765255
[TBL] [Abstract][Full Text] [Related]
9. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
[TBL] [Abstract][Full Text] [Related]
10. Mapping the COPD Assessment Test onto EQ-5D.
Hoyle CK; Tabberer M; Brooks J
Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
[TBL] [Abstract][Full Text] [Related]
11. Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis.
Martín-Fernández J; Morey-Montalvo M; Tomás-García N; Martín-Ramos E; Muñoz-García JC; Polentinos-Castro E; Rodríguez-Martínez G; Arenaza JC; García-Pérez L; Magdalena-Armas L; Bilbao A
Health Qual Life Outcomes; 2020 Jun; 18(1):184. PubMed ID: 32539838
[TBL] [Abstract][Full Text] [Related]
12. Mapping between the Roland Morris Questionnaire and generic preference-based measures.
Khan KA; Madan J; Petrou S; Lamb SE
Value Health; 2014 Sep; 17(6):686-95. PubMed ID: 25236992
[TBL] [Abstract][Full Text] [Related]
13. A mapping study in mainland China: predicting EQ-5D-5L utility scores from the psoriasis disability index.
Su J; Liu T; Li S; Zhao Y; Kuang Y
J Med Econ; 2020 Jul; 23(7):737-743. PubMed ID: 32223358
[No Abstract] [Full Text] [Related]
14. Estimating the association between SF-12 responses and EQ-5D utility values by response mapping.
Gray AM; Rivero-Arias O; Clarke PM
Med Decis Making; 2006; 26(1):18-29. PubMed ID: 16495197
[TBL] [Abstract][Full Text] [Related]
15. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
Moore A; Young CA; Hughes DA
Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
[TBL] [Abstract][Full Text] [Related]
16. Probabilistic mapping of the health status measure SF-12 onto the health utility measure EQ-5D using the US-population-based scoring models.
Le QA
Qual Life Res; 2014 Mar; 23(2):459-66. PubMed ID: 24026631
[TBL] [Abstract][Full Text] [Related]
17. Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia.
Meregaglia M; Borsoi L; Cairns J; Tarricone R
Eur J Health Econ; 2019 Mar; 20(2):181-193. PubMed ID: 28948436
[TBL] [Abstract][Full Text] [Related]
18. Mapping the PedsQL™ onto the CHU9D: An Assessment of External Validity in a Large Community-Based Sample.
Mpundu-Kaambwa C; Chen G; Huynh E; Russo R; Ratcliffe J
Pharmacoeconomics; 2019 Sep; 37(9):1139-1153. PubMed ID: 31161585
[TBL] [Abstract][Full Text] [Related]
19. Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea.
Lim J; Choi SE; Bae E; Kang D; Lim EA; Shin GS
Health Qual Life Outcomes; 2019 Jun; 17(1):97. PubMed ID: 31170982
[TBL] [Abstract][Full Text] [Related]
20. Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.
Rivero-Arias O; Ouellet M; Gray A; Wolstenholme J; Rothwell PM; Luengo-Fernandez R
Med Decis Making; 2010; 30(3):341-54. PubMed ID: 19858500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
